These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31727469)

  • 21. A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk mechanism.
    Gabl M; Holdfeldt A; Winther M; Oprea T; Bylund J; Dahlgren C; Forsman H
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1228-37. PubMed ID: 26996596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury.
    Ceruti S; Villa G; Genovese T; Mazzon E; Longhi R; Rosa P; Bramanti P; Cuzzocrea S; Abbracchio MP
    Brain; 2009 Aug; 132(Pt 8):2206-18. PubMed ID: 19528093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.
    Lambrecht G; Braun K; Damer M; Ganso M; Hildebrandt C; Ullmann H; Kassack MU; Nickel P
    Curr Pharm Des; 2002; 8(26):2371-99. PubMed ID: 12369951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.
    Baqi Y; Pillaiyar T; Abdelrahman A; Kaufmann O; Alshaibani S; Rafehi M; Ghasimi S; Akkari R; Ritter K; Simon K; Spinrath A; Kostenis E; Zhao Q; Köse M; Namasivayam V; Müller CE
    J Med Chem; 2018 Sep; 61(18):8136-8154. PubMed ID: 30048589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.
    Johansson H; Boesgaard MW; Nørskov-Lauritsen L; Larsen I; Kuhne S; Gloriam DE; Bräuner-Osborne H; Sejer Pedersen D
    J Med Chem; 2015 Nov; 58(22):8938-51. PubMed ID: 26516782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Ability of New Ligands for G Protein-Coupled Receptors 17 (GPR17).
    Zhuo T; Zhou S; Zhang W; Lambertucci C; Volpini R
    Med Sci Monit; 2017 Feb; 23():953-959. PubMed ID: 28223679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPR17 receptor modulators and their therapeutic implications: review of recent patents.
    Marucci G; Dal Ben D; Lambertucci C; Martí Navia A; Spinaci A; Volpini R; Buccioni M
    Expert Opin Ther Pat; 2019 Feb; 29(2):85-95. PubMed ID: 30640576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I
    Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP.
    Charlton SJ; Brown CA; Weisman GA; Turner JT; Erb L; Boarder MR
    Br J Pharmacol; 1996 Dec; 119(7):1301-3. PubMed ID: 8968535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction.
    Cosentino S; Castiglioni L; Colazzo F; Nobili E; Tremoli E; Rosa P; Abbracchio MP; Sironi L; Pesce M
    J Cell Mol Med; 2014 Sep; 18(9):1785-96. PubMed ID: 24909956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationships of 2-acylamino-4,6-diphenylpyridine derivatives as novel antagonists of GPR54.
    Kobayashi T; Sasaki S; Tomita N; Fukui S; Kuroda N; Nakayama M; Kiba A; Takatsu Y; Ohtaki T; Itoh F; Baba A
    Bioorg Med Chem; 2010 Jun; 18(11):3841-59. PubMed ID: 20457527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential for P2Y
    Jasmer KJ; Muñoz Forti K; Woods LT; Cha S; Weisman GA
    Purinergic Signal; 2023 Jun; 19(2):401-420. PubMed ID: 36219327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pharmacology of P2Y-receptors.
    von Kügelgen I; Wetter A
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):310-23. PubMed ID: 11111826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs.
    Kondej M; Wróbel TM; Silva AG; Stępnicki P; Koszła O; Kędzierska E; Bartyzel A; Biała G; Matosiuk D; Loza MI; Castro M; Kaczor AA
    Eur J Med Chem; 2019 Oct; 180():673-689. PubMed ID: 31357129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in porcine isolated arteries.
    Rayment SJ; Latif ML; Ralevic V; Alexander SP
    Br J Pharmacol; 2007 Mar; 150(5):604-12. PubMed ID: 17262017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats.
    Zhao B; Zhao CZ; Zhang XY; Huang XQ; Shi WZ; Fang SH; Lu YB; Zhang WP; Xia Q; Wei EQ
    Neuroscience; 2012 Jan; 202():42-57. PubMed ID: 22155652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair.
    Lecca D; Trincavelli ML; Gelosa P; Sironi L; Ciana P; Fumagalli M; Villa G; Verderio C; Grumelli C; Guerrini U; Tremoli E; Rosa P; Cuboni S; Martini C; Buffo A; Cimino M; Abbracchio MP
    PLoS One; 2008; 3(10):e3579. PubMed ID: 18974869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine.
    Fumagalli M; Lecca D; Coppolino GT; Parravicini C; Abbracchio MP
    Adv Exp Med Biol; 2017; 1051():169-192. PubMed ID: 28828731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of purinergic P2Y
    Li S; Hao G; Xu Y; Wang N; Li J; Geng X; Sun J
    Fish Shellfish Immunol; 2018 Apr; 75():208-215. PubMed ID: 29432865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of P2Y
    Neumann A; Attah I; Al-Hroub H; Namasivayam V; Müller CE
    J Chem Inf Model; 2022 Mar; 62(6):1538-1549. PubMed ID: 35285230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.